HHS Opens a Path to Compound BPC-157, TB-500 and Four Other Peptides: What the Policy Allows and What It Doesn’t
HHS filed a notice on October 28 letting licensed pharmacies compound six unapproved peptides, including BPC-157 and TB-500, under strict sourcing and reporting rules. Here is what the policy covers, what it does not, and five questions to ask any provider.









